| Description | Pristinamycin, synthesized by Streptomyces pristinaespiralis, is an orally administered antibiotic resembling streptogramin, comprising two distinct components: Pristinamycin I (PI) and Pristinamycin II (PII). This compound exhibits a high efficacy against various antibiotic-resistant pathogens, especially Gram-positive bacteria such as Methicillin-resistant Staphylococcus aureus (MRSA), Vancomycin-resistant S. aureus (VRSA), and Enterococcus faecium (VREF) [1]. |
| molecular weight | 1392.55 |
| Molecular formula | C73H89N11O17 |
| CAS | 270076-60-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |